Immediate and in-hospital outcome of percutaneous transvenous mitral commissurotomy in patients with mitral restenosis after previous surgical commissurotomy  by Toufiqur Rahman, Md. et al.
prognosis of patients withMR. Accurate assessment of ventricular
function and severity of MR using echocardiography alonemay be
difficult and bring us to diagnostic dead end. The use of echo-
cardiographic indices and biomarkers in combination can provide
an accurate assessment of MR severity and LV dysfunction. The
aim of this study is to assess correlation of NT Pro BNP levels with
echocardiographic indices in patients with MR.
Methods: The study population consisted of 50 patients diagnosed
to have MR. Transthoracic, M mode,2-Dimensional and Doppler
echocardiography performed using a Philips iE-33 machine. NT
pro BNP levels were measured by using Roche CARDIAC Pro BNP
test kit, Roche diagnostics limited, Germany and Cobas H 232 POC
system.
Results: BNP levels in groups with mild, moderate and severe MR
were 60 ± 6, 76±7.5, 78±6.6 pg/ml respectively (p¼0.162). Myocar-
dial performance index were 0.44±0.24, 0.42±0.23 & 0.53±0.28 in
patients with mild, moderate and severe MR respectively. But
there were no significant difference among three groups
(p¼0.404). BNP plasma levels were increased with symptoms in
patients with MR (NYHA I:60 ±5,NYHA II:102±6.5, NYHA
III:160±9pg/ml, p<0.001). BNP plasma levels were significantly
correlated with MPI (p¼0.004) and following echocardiographic
indices, LVEDV (p<0.001), LVESV p<0.001), LVEDD (p<0.001),
LVESD (p<0.001), LA dimension (p¼0.004) and negative correlation
with LV ejection fraction ( p<0.001),but there were no significant
correlations between BNP plasma level and MR volume (p¼0.33),
MR Vena contracta width (P¼0.23), MR Effective Regurgitant
Orifice Area (P¼0.34) and LA volume (p¼0.6)).
Conclusion: This study showed that BNP measurement has the
same sensitivity and specificity as echocardiographic indices and
may be used as a biomarker for the evaluation of patients with MR
in combination with echo indices.
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Background: Tricuspid valve disease frequently accompanies
rheumatic mitral valve disease.Organic tricuspid valve disease
with concomitant TS and TR is also frequent, and uncorrected
severe TR has been associated with adverse outcomes of both
BMV and surgical mitral valve reconstruction/replacement.
Methods: We retrospectively analysed patients in our hospital
who serially underwent concomitant balloon dilation of tricuspid
valve along with BMV and sought to determine predictors of
concomitant tricuspid valve disease requiring tricuspid valve
intervention, and clinical characteristics of patients undergoing
the same.Of the 12005 patients who underwent BMV at our
institute,10916 (91%) had some affection of tricuspid valve ,with
4716 (38.3%)found to have at least moderate TR or more.26 pa-
tients (0.21%)have undergone simultaneous TVBD, with 3 patients
having undergone the procedures twice. The decision to perform
TVBD during BMVwasmade according to trans-tricuspid gradient
measured as continuous wave signal across the “doming
“tricuspid valve , and difference of RVedp and RA mean pressures
by post BMV cath.The same Accura balloon that was used for BMV
was used for the TVBD( sizes 24,26,28) by withdrawing it across
the tricuspid valve.The balloon was dilated under fluoro guidance
till the waist of the stenosis across TV disappeared. Between serial
dilations, echo guidance was taken to assess result of previous
dilation.
Results: Patients undergoing BMV who underwent concomitant
tricuspid balloon dilation( Group A) for rheumatic TS were more
likely to be female (n¼21 of 26 patients( p< 0.001)),older(mean age:
30.5+/- 4.5 years ), more likely to present with right-sided symp-
toms , more likely have undergone a past valve procedure( either
BMV/CMV,n¼12) and have longer duration of disease( mean
duration: 11.4 +/-4.4 years,p< 0.001) than Group B patients.14 pa-
tients of the 26 ( group A) had AF (p<0.001) and were on oral
anticoagulation. Concomitant mitral involvement was seen 100%
patients, andmoderately advanced aortic valve disease (moderate
AR, mild to moderate AS) also was significantly more in group A
patients.
Pre-BMV trans-mitral gradients (due to the upstream TS,
however were not statistically significantly different between
groups A and B. The post procedural outcomes of the BMV with
TVBD in group A also did not reach significantly different values
as compared to those who underwent BMV alone. Though a
satisfactory initial result of TVBD was obtained in all patients,
most patients were referred for combined surgery in future
due to advanced disease with mitral, aortic and tricuspid
involvement.
Conclusions: Concomitant tricuspid involvement can be consid-
ered a frequent accompaniment of advanced rheumatic mitral
disease, and concomitant TVBD during BMV can be safe and
efficacious procedure with good immediate benefits but needing
mitral and tricuspid valve surgery in future. Higher patient age,
presence of AF and concomitant aortic disease probably are
pointers towards advanced age of disease in these patients.
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Background: Rheumatic fever and rheumatic heart disease
continue to be the major health problem in all developing coun-
tries including Bangladesh. Percutaneous Transvenous mitral
Commissurotomy (PTMC) is an established non-surgical modality
for the treatment of severe rheumatic mitral valve stenosis.The
purpose of this study was to evaluate our immediate and in-
hospital results of Percutaneous Transvenous Mitral Commis-
surotomy (PTMC) in patients with restenosis with previous mitral
surgery(CMC).
Methods: The study group included 880 consecutive patients who
underwent PTMC at the National Institute of cardiovascular Dis-
eases (NICVD), Dhaka and Al eHelal Heart Institute, Mirpur, Euro-
Bangla Heart Hospital, Lalmatia, Dhaka between May 2003 and
December 2012. Safety, efficacy and in-hospital results of percu-
taneous transvenous mitral commissurotomy were analyzed in
800 patients underwent PTMC without previous CMC (group 1)
and compared with 60 those of with previous CMC (group 2).
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Results: Baseline demographic and clinical characteristics were
similar in the 800 patients without previous CMC (group-1) and the
80 patients with previous CMC (group-2) during the procedure. In
thewhole study groupmitral valve area (MVA) was 0.85 ± 0.09 cm2
prior to PTMC, and increased to 1.76 ± 0.07 cm2 after the proce-
dure (p ¼ 0.0001). The mean increase in MVA was 0.78 ± 0.31 cm2
in the group-1 and 0.79 ± 0.41 cm2 in the group-2 (NS). During the
procedure or in-hospital after PTMC, embolic events were recor-
ded in 3 patients in group-1 and 2 patients in group-2 (NS). The
frequency of minor haematoma at puncture site in 15 patients in
group-1 vs 13 patients in group-2 and the development of peri-
cardial temponade and urgent pericardiocentesis in 3 patients in
group-1 vs 3 patients in group-2, were similar in both groups.
Conclusion: PTMC in selected patients withmitral restenosis after
previous surgical commissurotomy (CMC)can be performed safely
and with similar immediate efficacy and in-hospital outcome in
patients with Mitral stenosis.
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Background: Though the mitral annulus is an important compo-
nent of the mitral valve apparatus, there is little data on how it is
influenced by MS. We hypothesized that mitral annular (MA) dy-
namics are affected with increasing disease severity. We studied
acute alterations in MA dynamics in subjects undergoing BMV
using 3D transthoracic echocardiography (TTE) and explore their
role in predicting successful outcomes.
Methods: We prospectively enrolled consecutive subjects with
rheumatic MS in sinus rhythm. 41 MS subjects (36 ± 6 years; 70%
female) comprising mild (MVA  1.5 cm2; n ¼ 10), moderate (MVA
¼ 1.1 to 1.49 cm2; n¼13) and severe (MVA  1.0cm2; n ¼ 18) MS
subgroups were analyzed. Subjects with > grade I MR, mitral
annular calcification, hypertension, multi-valve or coronary ar-
tery disease, and LV dysfunction were excluded. All subjects un-
derwent 2D TTE and 3D TTE in keepingwith current guidelines. 3D
parameters including MA dimensions, antero-posterior and inter-
commissural diameters, systolic annular displacement and
displacement velocity were measured offline. Subjects were also
stratified based on mean value of annular displacement into low
MA ( 6.3 cm; n ¼20) and high MA (>6.3 cm; n ¼ 21) subgroups.
30 subjects (37 ± 8 years; 70% Female) with MS in sinus rhythm
were selected to undergo PTMC. MS subjects underwent an
additional study 24-48 hours after PTMC. 3D TTE based mitral
annular (MA) dimensions, non planar angle, annular displace-
ment and displacement velocities were measured offline
Results: Subjects with severe MS showed reduced annular
displacement (4.7 ± 2 vs. 9.8 ± 1.5cm; p < 0.01) and displacement
velocities (26.2 ± 8 vs. 41.6 ± 7cm/s; p <0.01) as compared to mild
MS, in addition to demonstrating higher mean gradient, LA vol-
ume and RVSP (p<0.001 for all variables). MA dimensions and
orthogonal diameters were not significantly different between
subgroups, though with increasing stenosis severity, a tendency
towards increased annular flattening was observed. MA
displacement was strongly correlated with valve area (r ¼ 0.74;
p<0.001), mean gradient (r ¼ -0.60; p<0.001) and RVSP (r ¼ -0.62;
p<0.001). Subjects with low MA displacement demonstrated
significantly smaller Mitral Valve Area (BMV) (0.8 ± 0.2vs. 1.3 ±
0.4cm2;p<0.001), highermean gradient (18 ± 7 vs. 10 ± 7mmHg; p¼
0.03) and RVSP ( 64 ± 29 vs. 35 ± 10mmHg ; p ¼ 0.001) as compared
to the high MA displacement subgroup.
In patients who underwent BMV, MVA increased (0.8 ± 0.1 to
1.63 ± 0.2 cm2) and transmitral mean gradient (19 ± 7 to 4 ±2 mm
Hg) and LA indexed volumes were reduced (71 ± 23 to 53 ± 18 mm
Hg)(p < 0.001 for all variables). Additionally, both annular
displacement (5.5 ± 2.0 to 7.4 ± 1.8cm; p < 0.01) and non planar
angles (153 ± 10 to 145 ± 8 degrees; p < 0.01) tended to normalize.
Subjects with unsuccessful outcomes (MVA < 1.5 cm2 or > grade II
MR; n ¼ 7) demonstrated no significant differences in Wilkins
score as compared to those with successful outcomes (10± 1.4 vs.
9.6 ± 0.7; n ¼ 23), but showed smaller anteroposterior diameters (
3.0 ± 0.1 vs. 3.3 ± 0.2; p < 0.05) and Ao-AP angles (139 ± 15 vs. 159 ±
10 degrees).
Conclusion: Mitral annular displacement and velocity are
decreased in severe MS. Progressive reduction in mitral annular
dynamics are associated with increasing disease severity. 3D TTE
derived MA dynamics demonstrate potential as novel additional
parameters to quantify MS severity.
MA displacement and velocity increases post BMV in patients
with MS, suggesting an improvement in MA dynamics and
normalization of 3D annular geometry. MA dynamics varied
significantly in patients with successful vs. unsuccessful BMV,
despite similar Wilkins score. MA dynamics may be a useful
marker to assess severity of MS and likelihood of success in pa-
tients undergoing BMV.
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Background: Rheumatic heart disease (RHD) is the most common
cause of valvular heart disease in India and other developing
countries accounting for 25-45% of acquired heart disease. RHD
especially regurgitant lesions of mitral and aortic valve and Aortic
stenosis are associated with left ventricular systolic dysfunction
later in their natural history. It is not clear based on present data,
whether this LV dysfunction is fully reversible if the mechanical
component is corrected by surgery. Cardiac magnetic resonance
imaging (MRI) to detect significant myocardial fibrosis may help
detecting patients with irreversible myocardial dysfunction with
poor recovery of LV function after surgery.
Methods:We retrospectively reviewed the records of RHD patients
with LV (Left ventricular) dysfunction (Left ventricular ejection
fraction, LVEF < 50%) by echocardiogram who underwent Cardiac
MRI. Patients with history or any evidence of previous acute cor-
onary syndrome or coronary artery disease, any other cardiomy-
opathies were excluded. We analysed what percentage of these
patients had significant late gadolinium enhancement (LGE) sug-
gestive of fibrosis on cardiac MRI, whether there was any corre-
lation of LGE with the degree of LV dysfunction and whether any
specific pattern of LGE was present in RHD patients.
Results: Cardiac MRI data of 17 patients (14 (82%)male) withmean
age 47.8 years (range 29-61) were analysed. 15 of the 17 patients
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